Agency Forms Undergoing Paperwork Reduction Act Review, 68887-68888 [2014-27350]

Download as PDF Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–27352 Filed 11–18–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-15–14APM] mstockstill on DSK4VPTVN1PROD with NOTICES Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written VerDate Sep<11>2014 16:16 Nov 18, 2014 Jkt 235001 comments should be received within 30 days of this notice. Proposed Project Surveillance of Health-Related Workplace Absenteeism—[New]— National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description There is currently a high global human health risk from emerging novel influenza, coronavirus and similar evolving pathogens, which is prompting the Centers for Disease Control and Prevention (CDC) to enhance situational awareness capacity for emergency preparedness and response. During the 2009 influenza A (H1N1) virus pandemic, NIOSH/CDC did a pilot study to test the feasibility of using national surveillance of workplace absenteeism to assess the pandemic’s impact on the workplace to plan for preparedness and continuity of operations and to contribute to health awareness during the emergency response. As part of this emergency effort, CDC contracted with the American College of Occupational and Environmental Medicine (ACOEM), which has access to a large network of affiliated medical directors and corporate health units that routinely compile absenteeism data, to conduct enhanced passive surveillance of absenteeism using weekly data from a convenience sample of sentinel worksites. Due the emergency situation at that time, OMB approval was erroneously not requested for the data collection activities associated with the pilot study. The current request seeks to build off of the data collected from the pilot and accounts for the burden involving all of the participants. From September 28, 2009, through March 31, 2010, 79 sentinel worksites representing 16 different employers participated in the pilot study. Each week, ACOEM collected reports of aggregated absenteeism data from the medical directors of the participating companies using an emailed, standardized form. ACOEM replaced company names with coded unique identifiers, and sent the aggregated data to CDC/NIOSH for analysis. The major strengths of the sentinel worksite approach to absenteeism surveillance were the use of existing, routinely collected data and timeliness. The use of existing, routinely collected data made the burden on participating companies negligible. Data were routinely compiled and thus could be collected and analyzed in near real time, PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 68887 making this approach useful, in principle, for providing current situational awareness and actionable intelligence that could be used to inform, prioritize, and evaluate intervention efforts during the pandemic. On the other hand, there were several limitations to the sentinel worksite surveillance done in 2009– 2010, and the activity was not maintained after the H1N1 pandemic ended. At present, two new emerging infectious diseases, novel H7N9 influenza virus and a coronavirus circulating in the Middle East, have demonstrated the need to build additional capacity for national surveillance for health-related workplace absenteeism so that it can be used to monitor the impact of these or any other disease that might reach pandemic potential and spread to the U.S. NIOSH/CDC requests permission to collect company absenteeism data, to be able to assess the impact of disease on a company and to identify trends in the spread of influenza or other novel disease states. This will provide an additional monitoring system to CDC. The proposed project builds on the 2009/10 initiative and modifies the reporting format to collect information on a daily versus weekly basis. The companies in the program will be those that routinely collect absenteeism data thus the burden will be minimal. We will be asking companies to record their daily absenteeism numbers into an excel file which can be emailed to ACOEM on a weekly or monthly basis. The excel file will be pre-populated with company name, site and dates to ease the reporting burden on companies. ACOEM will transmit de-identified information on a weekly or monthly basis to NIOSH/CDC who will in turn conduct analysis on an aggregate basis. Data will be compiled by state and HHS region, as well as nationally to allow for trend analysis. The initial 16 respondents in the 2009/10 study will be asked to participate and an additional 12 companies have indicated an interest in participating in the data collection activity. The employee population among these 28 companies is approximately 293,000. The annualized estimated burden of time is 607 hours for the 28 respondents in the study. Respondents will complete the form daily; no more than 5 minutes per day/per respondent which translates to 25 minutes per week/per respondent or 700 minutes per week for all respondents. This results in an E:\FR\FM\19NON1.SGM 19NON1 68888 Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices annualized burden of 607 hours per year. There are no costs to participants other than the time. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Form name Number of respondents Number of responses per respondent Average burden per response (in hours) Private companies .......................................... EXCEL data template .................................... 28 260 5/60 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–27350 Filed 11–18–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families [CFDA Numbers: 93.592] Announcing the Award of a SingleSource Program Expansion Supplement Grant to the National Resource Center on Domestic Violence (NRCDV) in Harrisburg, PA Family and Youth Services Bureau, ACYF, ACF, HHS. ACTION: Notice of the award of a singlesource program expansion supplement grant under the Family Violence Prevention and Services Act (FVPSA) Technical Assistance (TA) Project to the National Resource Center on Domestic Violence to support training and technical assistance activities. AGENCY: The Administration for Children and Families (ACF), Administration on Children, Youth and Families (ACYF), Family and Youth Services Bureau (FYSB), Division of Family Violence and Prevention Services (DFVPS) announces the award of $236,000 as a single-source program expansion supplement to the National Resource Center on Domestic Violence in Harrisburg, PA. The grantee, funded under the Family Violence Protection and Services Act (FVPSA) program, is a technical assistance (TA) provider that assists FVPSA service providers to build the capacity of domestic violence programs. DATES: The period of support for the single-source program expansion supplement is September 30, 2014 through September 29, 2015. FOR FURTHER INFORMATION CONTACT: Shawndell Dawson, Senior Program mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:16 Nov 18, 2014 Jkt 235001 Specialist, Family Violence Prevention and Services Program, 1250 Maryland Avenue SW., Suite 8219, Washington, DC 20024. Telephone: 202–205–1476; Email: Shawndell.Dawson@acf.hhs.gov. SUPPLEMENTARY INFORMATION: Supplemental award funds will support the grantee in providing training and technical assistance to domestic violence service providers. A portion of the supplemental award is contributed by the Centers for Disease Control (CDC) and Prevention’s National Center for Injury Prevention and Control (NCIPC), Division of Violence Prevention (DVP). This award will expand the scope of the NRCDV’s technical assistance activities to include additional activities concerning the prevention of intimate partner violence (IPV) by: (1) Coordinating engagement with nationallevel partners, including foundations, for the purpose of enhancing communication related to IPV prevention; 2) engaging in planning to facilitate dialogue that will include the sharing of tools and lessons learned among state domestic violence coalitions engaged in IPV primary prevention efforts; 3) continuing to identify and disseminate information on lessons learned and key findings from state domestic violence coalitions that have implemented IPV primary prevention activities through www.PreventIPVorg, and other means; 4) maintaining a virtual workspace to assist in the sharing of resources among state and territorial domestic violence coalitions that are engaged in IPV primary prevention activities; and 5) facilitating regular, ongoing communication between the IPV Prevention Council, ACF/DFVPS, and CDC/DVP. In addition to the prevention activities, the grantee will coordinate an accessibility and sustainability peer-topeer technical assistance collaborative with three to five state domestic violence coalitions, which may involve activities such as: (1) Identifying state coalitions with experience in addressing organizational accessibility challenges (i.e. mental health, substance use, men, and adolescent boys), or sustainability PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 challenges (i.e. fiscal management or board management); (2) coordinating support to domestic violence organizations or coalitions experiencing accessibility or sustainability challenges; and (3) developing peerinformed accessibility and sustainability tools and resources, and a discussion forum, for use by all domestic violence coalitions. Statutory Authority: Section 310 of the Family Violence Prevention and Services Act, as amended by Section 201 of the CAPTA Reauthorization Act of 2010, Pub. L. 111–320. The statutory authority for the additional funds from the Centers for Disease Control and Prevention is 42 U.S.C. 247b(k)(2) and 42 USC 280b–1 of the Public Health Service Act. Christopher Beach, Senior Grants Policy Specialist, Division of Grants Policy, Office of Administration. [FR Doc. 2014–27390 Filed 11–18–14; 8:45 am] BILLING CODE 4184–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–1855] Agency Information Collection Activities; Proposed Collection; Comment Request: Experimental Studies on Consumer Perceptions of Modified Risk Tobacco Products AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on Experimental Studies on Consumer Perceptions of Modified Risk Tobacco Products (MRTPs). SUMMARY: E:\FR\FM\19NON1.SGM 19NON1

Agencies

[Federal Register Volume 79, Number 223 (Wednesday, November 19, 2014)]
[Notices]
[Pages 68887-68888]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27350]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-15-14APM]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Surveillance of Health-Related Workplace Absenteeism--[New]--
National Institute for Occupational Safety and Health (NIOSH), Centers 
for Disease Control and Prevention (CDC).

Background and Brief Description

    There is currently a high global human health risk from emerging 
novel influenza, coronavirus and similar evolving pathogens, which is 
prompting the Centers for Disease Control and Prevention (CDC) to 
enhance situational awareness capacity for emergency preparedness and 
response.
    During the 2009 influenza A (H1N1) virus pandemic, NIOSH/CDC did a 
pilot study to test the feasibility of using national surveillance of 
workplace absenteeism to assess the pandemic's impact on the workplace 
to plan for preparedness and continuity of operations and to contribute 
to health awareness during the emergency response. As part of this 
emergency effort, CDC contracted with the American College of 
Occupational and Environmental Medicine (ACOEM), which has access to a 
large network of affiliated medical directors and corporate health 
units that routinely compile absenteeism data, to conduct enhanced 
passive surveillance of absenteeism using weekly data from a 
convenience sample of sentinel worksites.
    Due the emergency situation at that time, OMB approval was 
erroneously not requested for the data collection activities associated 
with the pilot study. The current request seeks to build off of the 
data collected from the pilot and accounts for the burden involving all 
of the participants.
    From September 28, 2009, through March 31, 2010, 79 sentinel 
worksites representing 16 different employers participated in the pilot 
study. Each week, ACOEM collected reports of aggregated absenteeism 
data from the medical directors of the participating companies using an 
emailed, standardized form. ACOEM replaced company names with coded 
unique identifiers, and sent the aggregated data to CDC/NIOSH for 
analysis.
    The major strengths of the sentinel worksite approach to 
absenteeism surveillance were the use of existing, routinely collected 
data and timeliness. The use of existing, routinely collected data made 
the burden on participating companies negligible. Data were routinely 
compiled and thus could be collected and analyzed in near real time, 
making this approach useful, in principle, for providing current 
situational awareness and actionable intelligence that could be used to 
inform, prioritize, and evaluate intervention efforts during the 
pandemic. On the other hand, there were several limitations to the 
sentinel worksite surveillance done in 2009-2010, and the activity was 
not maintained after the H1N1 pandemic ended.
    At present, two new emerging infectious diseases, novel H7N9 
influenza virus and a coronavirus circulating in the Middle East, have 
demonstrated the need to build additional capacity for national 
surveillance for health-related workplace absenteeism so that it can be 
used to monitor the impact of these or any other disease that might 
reach pandemic potential and spread to the U.S.
    NIOSH/CDC requests permission to collect company absenteeism data, 
to be able to assess the impact of disease on a company and to identify 
trends in the spread of influenza or other novel disease states. This 
will provide an additional monitoring system to CDC. The proposed 
project builds on the 2009/10 initiative and modifies the reporting 
format to collect information on a daily versus weekly basis. The 
companies in the program will be those that routinely collect 
absenteeism data thus the burden will be minimal. We will be asking 
companies to record their daily absenteeism numbers into an excel file 
which can be emailed to ACOEM on a weekly or monthly basis. The excel 
file will be pre-populated with company name, site and dates to ease 
the reporting burden on companies.
    ACOEM will transmit de-identified information on a weekly or 
monthly basis to NIOSH/CDC who will in turn conduct analysis on an 
aggregate basis. Data will be compiled by state and HHS region, as well 
as nationally to allow for trend analysis.
    The initial 16 respondents in the 2009/10 study will be asked to 
participate and an additional 12 companies have indicated an interest 
in participating in the data collection activity. The employee 
population among these 28 companies is approximately 293,000.
    The annualized estimated burden of time is 607 hours for the 28 
respondents in the study. Respondents will complete the form daily; no 
more than 5 minutes per day/per respondent which translates to 25 
minutes per week/per respondent or 700 minutes per week for all 
respondents. This results in an

[[Page 68888]]

annualized burden of 607 hours per year.
    There are no costs to participants other than the time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of      Average burden
         Type of respondent                  Form name            Number of      responses per     per response
                                                                 respondents       respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
Private companies...................  EXCEL data template....              28              260             5/60
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-27350 Filed 11-18-14; 8:45 am]
BILLING CODE 4163-18-P